Applications of nanotechnology for immunology

被引:575
作者
Smith, Douglas M. [1 ,2 ]
Simon, Jakub K. [3 ]
Baker, James R., Jr. [1 ,3 ]
机构
[1] Univ Michigan, Sch Med, Michigan Nanotechnol Inst Med & Biol Sci, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA
[3] NanoBio Corp, Ann Arbor, MI 48105 USA
关键词
VIRUS-LIKE PARTICLES; T-CELL RESPONSES; MUCOSAL IMMUNE-RESPONSES; INFLUENZA-A VIRUS; HEPATITIS-B; DENDRITIC CELLS; ANTIBODY-RESPONSE; CARBON NANOTUBES; IN-VITRO; SURFACTANT NANOEMULSION;
D O I
10.1038/nri3488
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Nanotechnology uses the unique properties of objects that function as a unit within the overall size range of 1-1,000 nanometres. The engineering of nanostructure materials, including nanoparticles, nanoemulsions or nanotubules, holds great promise for the development of new immunomodulatory agents, as such nanostructures can be used to more effectively manipulate or deliver immunologically active components to target sites. Successful applications of nanotechnology in the field of immunology will enable new generations of vaccines, adjuvants and immunomodulatory drugs that aim to improve clinical outcomes in response to a range of infectious and non-infectious diseases.
引用
收藏
页码:592 / 605
页数:14
相关论文
共 150 条
[1]  
Alexopoulos C. J., 1996
[2]   Structural characterization of the TCR complex by electron microscopy [J].
Arechaga, Ignacio ;
Swamy, Mahima ;
Abia, David ;
Schamel, Wolfgang A. ;
Alarcon, Balbino ;
Maria Valpuesta, Jose .
INTERNATIONAL IMMUNOLOGY, 2010, 22 (11) :897-903
[3]  
Babapoor S., 2012, INFLUENZA RES TREAT
[4]   Induction of mucosal immune responses by administration of liposome-antigen formulations and interleukin-12 [J].
Baca-Estrada, ME ;
Foldvari, M ;
Snider, M .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1999, 19 (05) :455-462
[5]  
Bachmann M. F., 2012, NATURE REV IMMUNOL, V10, P787
[6]   Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination [J].
Bal, Suzanne M. ;
Hortensius, Sander ;
Ding, Zhi ;
Jiskoot, Wim ;
Bouwstra, Joke A. .
VACCINE, 2011, 29 (05) :1045-1052
[7]   Partially Glycosylated Dendrimers Block MD-2 and Prevent TLR4-MD-2-LPS Complex Mediated Cytokine Responses [J].
Barata, Teresa S. ;
Teo, Ian ;
Brocchini, Steve ;
Zloh, Mire ;
Shaunak, Sunil .
PLOS COMPUTATIONAL BIOLOGY, 2011, 7 (06)
[8]   The adjuvants MF59 and LT-K63 enhance the mucosal and systemic immunogenicity of subunit influenza vaccine administered intranasally in mice [J].
Barchfeld, GL ;
Hessler, AL ;
Chen, M ;
Pizza, M ;
Rappuoli, R ;
Van Nest, GA .
VACCINE, 1999, 17 (7-8) :695-704
[9]   Repetitive versus monomeric antigen presentation:: direct visualization of antibody affinity and specificity [J].
Baschong, W ;
Hasler, L ;
Häner, M ;
Kistler, J ;
Aebi, U .
JOURNAL OF STRUCTURAL BIOLOGY, 2003, 143 (03) :258-262
[10]   Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults [J].
Bernstein, David I. ;
Edwards, Kathryn M. ;
Dekker, Cornelia L. ;
Belshe, Robert ;
Talbot, Helen K. B. ;
Graham, Irene L. ;
Noah, Diana L. ;
He, Fenhua ;
Hill, Heather .
JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (05) :667-675